Home » Newsletters » BioWorld

BioWorld

April 28, 1993

View Archived Issues

CRYOPHARM EXTENDS SHELF LIFE OF RBCS

GYNEX REPORTS OXANDRIN RESULTS

UBI EXTENDS AIDS VACCINE TRIALS

BRITISH BIO BEGINS PHASE II TRIAL

BIORELEASE BEGINS SALES OF ERYTHROGEN

GENZYME ACQUIRES GERMAN COMPANY

UNIVAX LICENSES ADJUVANT

APPOINTMENTS AND ADVANCEMENTS

CAMBRIDGE NEURO GETS SBIR FOR CHANNEL BLOCKERS

RESPIVIR EFFECTIVE AGAINST RSV

PTO ALLOWS KEY T CELL PATENT

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...